BridgeBio Oncology Therapeutics Inc. (BBOT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for BridgeBio Oncology Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | -2.91x | -2.35x | -3.23x | -59301.75x | -4814.50x |
| P/B Ratio | 0.95x | 0.93x | -3283.71x | -9541.63x | -11371.26x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | |||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | |||||
| Current Ratio | 12.14x | 10.40x | 0.00x | 0.00x | 0.00x |
| Quick Ratio | 12.14x | 10.40x | 0.00x | 0.00x | 0.00x |
| Leverage | |||||
| Debt/Equity | 0.01x | 0.00x | -1.10x | -1.97x | -2.01x |
YoY = year-over-year change. Source: FMP..